血管生成拟态
生物
鼻咽癌
过剩1
癌症研究
下调和上调
组蛋白H3
葡萄糖转运蛋白
癌症
细胞生物学
转移
组蛋白
内科学
内分泌学
生物化学
遗传学
基因
医学
胰岛素
放射治疗
作者
Xianjie Jiang,Xiangying Deng,Jie Wang,Yongzhen Mo,Lei Shi,Wei Fang,Shanshan Zhang,Zhaojian Gong,Yi He,Fang Xiong,Yumin Wang,Can Jie Guo,Bo Xiang,Ming Zhou,Qianjin Liao,Xiaoling Li,Yong Li,Guiyuan Li,Wei Xiong,Zhaoyang Zeng
出处
期刊:Oncogene
[Springer Nature]
日期:2021-11-01
卷期号:41 (2): 233-245
被引量:58
标识
DOI:10.1038/s41388-021-02079-8
摘要
Abstract BackgroundNasopharyngeal carcinoma (NPC) exhibits significant regional differences and a high incidence in Southeast Asia and southern China. Bactericidal/permeability-increasing-fold-containing family B member 1 (BPIFB1) is a relatively specific and highly expressed protein in the nasopharyngeal epithelium. Accumulating evidence indicates that BPIFB1 is substantially downregulated in NPC and low BPIFB1 is associated with NPC patient’s poor prognosis. However, the clear molecular mechanism by which BPIFB1 regulates NPC is not well understood.MethodsThe expression of BPIFB1 was analyzed by immunohistochemistry(IHC) and the vasculogenic mimicry was examined by CD31/PAS double staining in NPC clinical samples. The regulation of BPIFB1 on vasculogenic mimicry in vitro and in vivo were performed by tube formation assay and xenograft assay respectively. ECAR was analyzed by Seahorse XF analyzer. 2-NBDG uptake was detected by FACS. Glucose consumption and lactate production were analyzed by Automatic Biochemical Analyzer. Downstream targets of BPIFB1 were validated by western blot, qPCR, Chip-qRT-PCR and dual luciferase reporter assay. Lastly, immunohistochemistry(IHC) was performed to confirm the relationship between BPIFB1 and related genes in NPC clinical samples. ResultsIn this study, we show that BPIFB1 plays an important role in regulating vasculogenic mimicry. Ectopic expression of BPIFB1 significantly inhibits vasculogenic mimicry. Mechanistically, we show that BPIFB1 can inhibits JNK/AP1 signaling which leads to inhibition of glucose transporter 1 (GLUT1) transcription and glycolysis, consequently, resulting in reducing histone H3K27 acetylation and decreasing the expression of vasculogenic mimicry-related VEGFA, VE-cadherin, and MMP2. ConclusionThis study demonstrates that BPIFB1 has a novel biological function in inhibiting glycolysis and vasculogenic mimicry and highlights that BPIFB1 is a potential target for NPC diagnosis and treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI